IndustriesIndustrial

Products 21 to 30 of 91

BioIsoprene by DuPont
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Biotech components: Bacteria
Business models: B2C
Country of production: France
Country of distribution: France
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/19 11:53 (6 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: N/A
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (6 years ago)
Date last modified: 2018/11/19 09:36 (6 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Early Stage Concept + More information needed
Organization type(s): Private Company
Product categories: Construction + Design + Resource Extraction
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biolon DDDA by Verdezyne
Biotech components: Plant
Business models: B2B
Country of production: Malaysia
Country of distribution: Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:44 (6 years ago)
Known funding amount: 86,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biopolymer I6001 by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:56 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer I6003rp by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:56 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5010 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5011 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 15:45 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Cellic CTec by Novozymes
Biotech components: Enzyme
Business models: B2B
Country of production: Denmark
Country of distribution: USA + Italy
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 29,300,000 USD
Funding types: Shareholder Investment + Government
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: NZYM-B (CPH)
Value chain stage: Input